SEC Form 4 · accession 0001209191-18-008073
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Belsky
Officer — Senior Vice President and CFO
Period of report
Feb 5, 2018
Accepted (ET)
Feb 7, 2018 · 2:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2018 | F | 1,048 | $18.42 | D | 13,314 | D | |
| Common StockF1 | holding | — | — | — | 44,158 | I | By the Belsky Living Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The allocation of direct and indirect ownership of shares in this ownership report differ from the reporting person's last ownership report as a result of the inadvertent disclosure of 1,793 shares as being owned directly, rather than indirectly, by the reporting person.